Moreover, multivariate Cox regression analyses showed that expression of DUXAP10 (p=0.013), along with TNM stage (P=0.023) and lymph node metastasis(p=0.029), were independent prognostic factors for NSCLC patients (Table 2). This evidence concerns the gene DUXAP10 and metastatic malignant neoplasm in the lymph nodes.